GALECTIN-14 THERAPEUTIC MOLECULE AND USES THEREOF
The present invention relates generally to a novel galectin and to derivatives, homologues, analogues, chemical equivalents and mimetics thereof capable of modulating an immune response and, in particularly, an inflammatory response. More particularly, the present invention relates to ecalectin-like...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DUNPHY, JILLIAN, LEE NASH, ANDREW YOUNG, ANNA, RACHEL MEEUSEN, ELZA, NICOLE, THERESIA BARCHAM, GARRY |
| description | The present invention relates generally to a novel galectin and to derivatives, homologues, analogues, chemical equivalents and mimetics thereof capable of modulating an immune response and, in particularly, an inflammatory response. More particularly, the present invention relates to ecalectin-like galectin (herein referred to as "galectin-14") and to derivatives, homologues, analogues, chemical equivalents and mimetics of said protein sequence. The present invention also contemplates genetic sequences encoding said galectin and derivatives, homologues, analogues, chemical equivalents and mimetics thereof. The molecules of the present invention are useful in a range of therapeutic, prophylactic and diagnostic applications.
L'invention concerne, de façon générale, une galectine et des dérivés, homologues, analogues, équivalents chimiques et substances mimétiques de cette galectine pouvant moduler une réponse immune et, en particulier, une réponse inflammatoire. Elle concerne, plus particulièrement, une galectine de type écalectine (dénommée ici "galectine-14") et des dérivés, homologues, analogues, équivalents chimiques et substances mimétiques de cette séquence de protéine. Elle concerne enfin des séquences génétiques codant pour cette galectine et ses dérivés, homologues, analogues, équivalents et substances mimétiques. Les molécules de cette invention sont utiles dans le domaine des applications thérapeutiques, prophylactiques et de diagnostic. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO03008580A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO03008580A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO03008580A13</originalsourceid><addsrcrecordid>eNrjZDB0d_RxdQ7x9NM1NFEI8XANcgxwDQ3xdFbw9QeKh_q4Kjj6uSiEBrsGg2Vd_d14GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakl8uL-BsYGBhamFgaOhMTFqADWKJmE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GALECTIN-14 THERAPEUTIC MOLECULE AND USES THEREOF</title><source>esp@cenet</source><creator>DUNPHY, JILLIAN, LEE ; NASH, ANDREW ; YOUNG, ANNA, RACHEL ; MEEUSEN, ELZA, NICOLE, THERESIA ; BARCHAM, GARRY</creator><creatorcontrib>DUNPHY, JILLIAN, LEE ; NASH, ANDREW ; YOUNG, ANNA, RACHEL ; MEEUSEN, ELZA, NICOLE, THERESIA ; BARCHAM, GARRY</creatorcontrib><description>The present invention relates generally to a novel galectin and to derivatives, homologues, analogues, chemical equivalents and mimetics thereof capable of modulating an immune response and, in particularly, an inflammatory response. More particularly, the present invention relates to ecalectin-like galectin (herein referred to as "galectin-14") and to derivatives, homologues, analogues, chemical equivalents and mimetics of said protein sequence. The present invention also contemplates genetic sequences encoding said galectin and derivatives, homologues, analogues, chemical equivalents and mimetics thereof. The molecules of the present invention are useful in a range of therapeutic, prophylactic and diagnostic applications.
L'invention concerne, de façon générale, une galectine et des dérivés, homologues, analogues, équivalents chimiques et substances mimétiques de cette galectine pouvant moduler une réponse immune et, en particulier, une réponse inflammatoire. Elle concerne, plus particulièrement, une galectine de type écalectine (dénommée ici "galectine-14") et des dérivés, homologues, analogues, équivalents chimiques et substances mimétiques de cette séquence de protéine. Elle concerne enfin des séquences génétiques codant pour cette galectine et ses dérivés, homologues, analogues, équivalents et substances mimétiques. Les molécules de cette invention sont utiles dans le domaine des applications thérapeutiques, prophylactiques et de diagnostic.</description><edition>7</edition><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030130&DB=EPODOC&CC=WO&NR=03008580A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030130&DB=EPODOC&CC=WO&NR=03008580A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DUNPHY, JILLIAN, LEE</creatorcontrib><creatorcontrib>NASH, ANDREW</creatorcontrib><creatorcontrib>YOUNG, ANNA, RACHEL</creatorcontrib><creatorcontrib>MEEUSEN, ELZA, NICOLE, THERESIA</creatorcontrib><creatorcontrib>BARCHAM, GARRY</creatorcontrib><title>GALECTIN-14 THERAPEUTIC MOLECULE AND USES THEREOF</title><description>The present invention relates generally to a novel galectin and to derivatives, homologues, analogues, chemical equivalents and mimetics thereof capable of modulating an immune response and, in particularly, an inflammatory response. More particularly, the present invention relates to ecalectin-like galectin (herein referred to as "galectin-14") and to derivatives, homologues, analogues, chemical equivalents and mimetics of said protein sequence. The present invention also contemplates genetic sequences encoding said galectin and derivatives, homologues, analogues, chemical equivalents and mimetics thereof. The molecules of the present invention are useful in a range of therapeutic, prophylactic and diagnostic applications.
L'invention concerne, de façon générale, une galectine et des dérivés, homologues, analogues, équivalents chimiques et substances mimétiques de cette galectine pouvant moduler une réponse immune et, en particulier, une réponse inflammatoire. Elle concerne, plus particulièrement, une galectine de type écalectine (dénommée ici "galectine-14") et des dérivés, homologues, analogues, équivalents chimiques et substances mimétiques de cette séquence de protéine. Elle concerne enfin des séquences génétiques codant pour cette galectine et ses dérivés, homologues, analogues, équivalents et substances mimétiques. Les molécules de cette invention sont utiles dans le domaine des applications thérapeutiques, prophylactiques et de diagnostic.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB0d_RxdQ7x9NM1NFEI8XANcgxwDQ3xdFbw9QeKh_q4Kjj6uSiEBrsGg2Vd_d14GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakl8uL-BsYGBhamFgaOhMTFqADWKJmE</recordid><startdate>20030130</startdate><enddate>20030130</enddate><creator>DUNPHY, JILLIAN, LEE</creator><creator>NASH, ANDREW</creator><creator>YOUNG, ANNA, RACHEL</creator><creator>MEEUSEN, ELZA, NICOLE, THERESIA</creator><creator>BARCHAM, GARRY</creator><scope>EVB</scope></search><sort><creationdate>20030130</creationdate><title>GALECTIN-14 THERAPEUTIC MOLECULE AND USES THEREOF</title><author>DUNPHY, JILLIAN, LEE ; NASH, ANDREW ; YOUNG, ANNA, RACHEL ; MEEUSEN, ELZA, NICOLE, THERESIA ; BARCHAM, GARRY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO03008580A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2003</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>DUNPHY, JILLIAN, LEE</creatorcontrib><creatorcontrib>NASH, ANDREW</creatorcontrib><creatorcontrib>YOUNG, ANNA, RACHEL</creatorcontrib><creatorcontrib>MEEUSEN, ELZA, NICOLE, THERESIA</creatorcontrib><creatorcontrib>BARCHAM, GARRY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DUNPHY, JILLIAN, LEE</au><au>NASH, ANDREW</au><au>YOUNG, ANNA, RACHEL</au><au>MEEUSEN, ELZA, NICOLE, THERESIA</au><au>BARCHAM, GARRY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GALECTIN-14 THERAPEUTIC MOLECULE AND USES THEREOF</title><date>2003-01-30</date><risdate>2003</risdate><abstract>The present invention relates generally to a novel galectin and to derivatives, homologues, analogues, chemical equivalents and mimetics thereof capable of modulating an immune response and, in particularly, an inflammatory response. More particularly, the present invention relates to ecalectin-like galectin (herein referred to as "galectin-14") and to derivatives, homologues, analogues, chemical equivalents and mimetics of said protein sequence. The present invention also contemplates genetic sequences encoding said galectin and derivatives, homologues, analogues, chemical equivalents and mimetics thereof. The molecules of the present invention are useful in a range of therapeutic, prophylactic and diagnostic applications.
L'invention concerne, de façon générale, une galectine et des dérivés, homologues, analogues, équivalents chimiques et substances mimétiques de cette galectine pouvant moduler une réponse immune et, en particulier, une réponse inflammatoire. Elle concerne, plus particulièrement, une galectine de type écalectine (dénommée ici "galectine-14") et des dérivés, homologues, analogues, équivalents chimiques et substances mimétiques de cette séquence de protéine. Elle concerne enfin des séquences génétiques codant pour cette galectine et ses dérivés, homologues, analogues, équivalents et substances mimétiques. Les molécules de cette invention sont utiles dans le domaine des applications thérapeutiques, prophylactiques et de diagnostic.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO03008580A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | GALECTIN-14 THERAPEUTIC MOLECULE AND USES THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T19%3A12%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DUNPHY,%20JILLIAN,%20LEE&rft.date=2003-01-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO03008580A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |